Cadinha & Co. LLC increased its stake in shares of Danaher Corporation (NYSE:DHR) by 1.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 243,108 shares of the conglomerate’s stock after acquiring an additional 2,706 shares during the period. Danaher Corporation comprises about 3.6% of Cadinha & Co. LLC’s portfolio, making the stock its 7th largest position. Cadinha & Co. LLC’s holdings in Danaher Corporation were worth $20,516,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Schwab Charles Investment Management Inc. raised its holdings in shares of Danaher Corporation by 5.0% during the second quarter. Schwab Charles Investment Management Inc. now owns 1,972,012 shares of the conglomerate’s stock worth $166,419,000 after acquiring an additional 94,763 shares during the period. Canada Pension Plan Investment Board raised its holdings in shares of Danaher Corporation by 29.7% during the second quarter. Canada Pension Plan Investment Board now owns 656,467 shares of the conglomerate’s stock worth $55,399,000 after acquiring an additional 150,400 shares during the period. Arrow Financial Corp raised its holdings in shares of Danaher Corporation by 2.3% during the second quarter. Arrow Financial Corp now owns 2,264 shares of the conglomerate’s stock worth $191,000 after acquiring an additional 51 shares during the period. Global X Management Co. LLC raised its holdings in shares of Danaher Corporation by 14.5% during the second quarter. Global X Management Co. LLC now owns 3,608 shares of the conglomerate’s stock worth $304,000 after acquiring an additional 458 shares during the period. Finally, HL Financial Services LLC raised its holdings in shares of Danaher Corporation by 10.1% during the second quarter. HL Financial Services LLC now owns 7,847 shares of the conglomerate’s stock worth $662,000 after acquiring an additional 722 shares during the period. Institutional investors and hedge funds own 75.68% of the company’s stock.

Danaher Corporation (NYSE:DHR) opened at 88.21 on Monday. The stock has a 50 day moving average of $82.64 and a 200-day moving average of $84.22. The company has a market cap of $61.28 billion, a P/E ratio of 28.16 and a beta of 1.03. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.48.

Danaher Corporation (NYSE:DHR) last announced its earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.02. The company had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.90 earnings per share. Equities research analysts expect that Danaher Corporation will post $3.95 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be issued a $0.14 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.63%. Danaher Corporation’s dividend payout ratio is currently 17.83%.

WARNING: “Cadinha & Co. LLC Buys 2,706 Shares of Danaher Corporation (DHR)” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.dailypolitical.com/2017/09/18/cadinha-co-llc-buys-2706-shares-of-danaher-corporation-dhr.html.

In other news, Director Linda P. Hefner sold 10,578 shares of the stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the sale, the director now owns 42,151 shares in the company, valued at $3,499,797.53. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider William King sold 7,458 shares of the stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $82.97, for a total transaction of $618,790.26. Following the completion of the sale, the insider now owns 18,245 shares of the company’s stock, valued at approximately $1,513,787.65. The disclosure for this sale can be found here. In the last quarter, insiders sold 71,496 shares of company stock valued at $5,916,223. 12.20% of the stock is currently owned by corporate insiders.

A number of brokerages recently commented on DHR. Wells Fargo & Company restated a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Jefferies Group LLC restated a “buy” rating and set a $95.00 price objective on shares of Danaher Corporation in a report on Friday, August 4th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Credit Suisse Group reaffirmed a “buy” rating and issued a $93.00 target price on shares of Danaher Corporation in a research report on Wednesday, May 24th. Finally, Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. Danaher Corporation currently has a consensus rating of “Buy” and a consensus target price of $92.72.

Danaher Corporation Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.